Online Treatment Tool for Patients: Key Information You Need to Know About Your Follicular Lymphoma Diagnosis

Download this PDF consultation checklist with useful questions for your oncologist about your new follicular lymphoma diagnosis. You can then enter the specific information about your cancer into our interactive treatment tool by answering a series of multiple choice questions to get treatment options chosen by 5 lymphoma experts.
John M. Burke, MD
Ian W. Flinn, MD, PhD
Christopher R. Flowers, MD, MS
Nathan H. Fowler, MD
Jeff P. Sharman, MD
Format: Adobe Acrobat (.pdf)
File Size: 93 KB
Released: October 4, 2018


Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)

Produced in collaboration with
Grace Logo
This activity is supported by an educational grant from

Related Content

How to use dual HER2-targeted adjuvant therapy with trastuzumab and pertuzumab and extended therapy with neratinib for patients with HER2+ EBC

person default Madelaine Kuiper, NP Registered Nurses: 1.0 Nursing contact hour Released: November 13, 2018 Expiration: November 12, 2019

Stephen Ansell, MD, PhD presents data on treating patients with newly diagnosed mantel cell lymphoma and how to use ibrutinib and acalabrutinib after progression.

Stephen Ansell, MD, PhD Released: November 13, 2018

Downloadable slides with expert advice for managing patients with non-small-cell lung cancer (NSCLC) using the latest treatment strategies.

Jonathan Dowell, MD
Program Director
Melissa L. Johnson, MD
Program Director
Released: November 13, 2018

Stephen Ansell, MD, PhD, reviews practice-changing data and expert recommendations for treating patients with mantle cell lymphoma (MCL).

Stephen Ansell, MD, PhD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: November 13, 2018 Expiration: November 12, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?